Skip to content

Study · Measured the body's own peptide · 1983

2 results

Demonstration of abnormalities in expression of thymic epithelial surface antigens in severe cellular immunodeficiency diseases.

Haynes BF, Warren RW, Buckley RH, McClure JE, Goldstein AL, Henderson FW, Hensley LL, Eisenbarth GS

Journal of immunology (Baltimore, Md. : 1950)1 Mar 1983Cited by 29 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

No result from this study comes from a test of the peptide.

Natural levels measured2

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01HumanEndogenous levelObservational studyOther

    Thymic epithelium from patients with SCID and Nezelof syndrome contained thymosin beta‑4.

    In plain wordsIn thymus tissue from patients with severe immune deficiency, the body's own thymosin beta‑4 was present.

    Outcome
    Not applicableThymosin beta 4 in thymic epithelium of immunodeficiency patients
    Study

    n = 3

    Thymic epithelium from patients with severe cellular immunodeficiency
    Outcome group
    Endogenous peptide levels · Immune and inflammation

    Source sentences

    Summary
    Thymic epithelium from both SCID and Nezelof syndrome patients contained thymosin alpha 1, thymopoietin, and thymosin beta 4 and expressed human Thy-1 antigen.
    1 context sentence
    Summary · context
    Thymic epithelium from three patients with severe cellular immunodeficiency diseases were compared with age-matched normal thymic epithelium using three markers of human thymic epithelium and antibodies against thymosin alpha 1, thymopoietin, and thymosin beta 4.

    This result measures the body's own Thymosin beta-4 (human). Nobody was given the peptide. It is not evidence about taking it.

  2. 02LabEndogenous levelEx vivo tissueOther

    Thymic epithelium from patients with SCID and Nezelof syndrome contained thymosin alpha‑1.

    In plain wordsIn lab tests on thymus tissue with severe immune deficiency, the body's own thymosin alpha‑1 was present in thymic epithelium.

    Outcome
    Not applicableThymosin alpha 1 in thymic epithelium of immunodeficiency patients
    Study

    humann = 3

    thymic epithelium tissue sections
    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    Thymic epithelium from both SCID and Nezelof syndrome patients contained thymosin alpha 1, thymopoietin, and thymosin beta 4
    1 context sentence
    Summary · context
    Thymic epithelium from three patients with severe cellular immunodeficiency diseases were compared with age-matched normal thymic epithelium using three markers of human thymic epithelium and antibodies against thymosin alpha 1, thymopoietin, and thymosin beta 4.

    This result measures the body's own Thymosin alpha-1. Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 4Current

    12 Oct 2026, 18:17 UTC

    Study data updated · source update from Europe PMC

  2. Version 3

    10 Oct 2026, 08:55 UTC

    Study results updated

  3. Version 2

    9 Oct 2026, 03:03 UTC

    Study data updated · source update from Europe PMC

  4. Version 1

    9 Oct 2026, 03:02 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.